4 results on '"Gutiérrez, Silvina"'
Search Results
2. Evidence of cellular senescence during the development of estrogen-induced pituitary tumors.
- Author
-
Sabatino, Maria Eugenia, Petiti, Juan Pablo, del Valle Sosa, Liliana, Pérez, Pablo Anibal, Gutiérrez, Silvina, Leimgruber, Carolina, Latini, Alexandra, Torres, Alicia Inés, and De Paul, Ana Lucía
- Subjects
PITUITARY tumors ,ESTROGEN ,METASTASIS ,CELL proliferation ,TRANSFORMING growth factors ,LABORATORY rats - Abstract
Although pituitary adenomas represent 25% of intracranial tumors, they are usually benign, with the mechanisms by which these tumors usually avoid an invasive profile and metastatic growth development still remaining unclear. In this context, cellular senescence might constitute a plausible explanation for the benign nature of pituitary adenomas. In this study, we investigated the emergence of cellular senescence as a growth control mechanism during the progression of estrogen-induced pituitary tumors. The quantification of Ki67- immunopositive cells in the pituitaries of estrogenized male rats after 10, 20, 40, and 60 days revealed that the mitogenic potential rate was not sustained for the whole period analyzed and successively decreased after 10 days of estrogen exposure. In addition, the expression of cellular senescence features, such as the progressive rise in the enzymatic senescenceassociated b-galactosidase (SA-b-gal) activity, IL6, IL1b, and TGFb expression, was observed throughout pituitary tumor development. Furthermore, tumoral pituitary cells also displayed nuclear pATM expression, indicating activated DNA damage signaling, with a significant increase in p21 expression also being detected. The associations among DNA damage signaling activation, SA-b-gal expression, and p21 may provide a reliable combination of senescence-associated markers for in vivo pituitary senescence detection. These results suggest a role for this cellular process in the regulation of pituitary cell growth. Thus, cellular senescence should be conceived as a contributing component to the benign nature of pituitary adenomas, thereby influencing the capability of the pituitary gland to avoid unregulated cell proliferation. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
3. Estradiol interacts with insulin through membrane receptors to induce an antimitogenic effect on lactotroph cells
- Author
-
Gutiérrez, Silvina, De Paul, Ana Lucía, Petiti, Juan Pablo, del Valle Sosa, Liliana, Palmeri, Claudia Mariela, Soaje, Marta, Orgnero, Elsa Margarita, and Torres, Alicia Inés
- Subjects
- *
ESTROGEN , *ESTRADIOL , *BLOOD plasma , *SEX hormones - Abstract
Abstract: The signaling mechanisms of estrogens interact with those of growth factors to control the pituitary gland functions. The contribution of the membrane bound estrogen receptor in these actions is not fully understood. In this study, we focused on the regulatory action of estradiol in interaction with insulin on the secretory and proliferative lactotroph cell activities from primary pituitary cell cultures. Furthermore, we studied the involvement of ERK1/2, PKC epsilon and Pit-1 in these actions. In serum free conditions, estradiol and estradiol-BSA promoted a differential secretory activity on PRL cells but were unable to induce lactotroph cell proliferation. However, both free and conjugated estradiol were competent arresting the mitogenic activity promoted by insulin. Estradiol, estradiol-BSA and insulin stimuli increased the PKC epsilon, phosphorylated ERK 1/2 and Pit-1 expression, although combined treatments with estradiol/insulin or estradiol-BSA/insulin induced a significant reduction in these levels, in close correlation with the decrease of lactotroph cell proliferation. The pre-treatment with PKC inhibitor BIM significantly inhibited the ERK activation promoted by insulin without modifying the ERK expression levels induced by estradiol or estradiol-BSA. By immuno-electron-microscopy the alpha nuclear estrogen receptor was localized in the plasma membrane of lactotroph cells. These findings suggest that the membrane bound ER participates modulating lactotroph cells proliferation via PKC epsilon, ERK1/2 and Pit-1. The interactions between estradiol and growth factors, inducing both mitogenic and antimitogenic effects, could provide glandular plasticity preventing an over-proliferation induced by growth factors. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
4. Bromocriptine induces parapoptosis as the main type of cell death responsible for experimental pituitary tumor shrinkage
- Author
-
Palmeri, Claudia Mariela, Petiti, Juan Pablo, del Valle Sosa, Liliana, Gutiérrez, Silvina, De Paul, Ana Lucía, Mukdsi, Jorge Humberto, and Torres, Alicia Inés
- Subjects
- *
BROMOCRIPTINE , *APOPTOSIS , *EFFECT of drugs on cells , *CELL death , *PITUITARY tumors , *DISEASE remission , *BIOLOGY experiments , *LABORATORY rats , *ESTROGEN , *MITOGEN-activated protein kinases - Abstract
Abstract: Bromocriptine (Bc) produces pituitary tumoral mass regression which induces the cellular death that was classically described as apoptosis. However, recent works have related that other mechanisms of cell death could also be involved in the maintenance of physiological and pathological pituitary homeostasis. The aim of this study was to evaluate and characterize the different types of cell death in the involution induced by Bc in experimental rat pituitary tumors. The current study demonstrated that Bc induced an effective regression of estrogen induced pituitary tumors by a mechanism identified as parapoptosis. This alternative cell death was ultrastructurally recognized by extensive cytoplasmic vacuolization and an increased cell electron density, represented around 25% of the total pituitary cells counted. Furthermore, the results obtained from biochemical assays did not correspond to the criteria of apoptosis or necrosis. We also investigated the participation of p38, ERK1/2 and PKCδ in the parapoptotic pathway. An important observation was the significant increase in phosphorylated forms of these MAPKs, the holoenzyme and catalytic fragments of PKCδ in nuclear fractions after Bc administration compared to control and estrogen treated rats. Furthermore, the immunolocalization at ultrastructural level of these kinases showed a similar distribution pattern, with a prevalent localization at nuclear level in lactotrophs from Bc treated rats. In summary, we determined that parapoptosis is the predominant cell death type involved in the regression of pituitary tumors in response to Bc treatment, and may cause the activation of PKCδ, ERK1/2 and p38. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.